Skip to content
TrialScanner

NCT00626236

Phase 2a Study of Safety and Tolerability of SPN-810 in Children With ADHD and Persistent Serious Conduct Problems

Phase 2CompletedSUPNLead

Registry record

Lead sponsor
Supernus Pharmaceuticals, Inc.
Conditions
Attention Deficit Disorder With Hyperactivity; Conduct Disorder
Primary completion
Sep 23, 2009Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT00626236 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT00626236: Phase 2a Study of Safety and... | TrialScanner